Dengue
Our R&D portfolio for dengue
What we have achieved
We are bringing together partners in dengue-endemic countries to find urgently needed treatments for dengue.
We established the Dengue Alliance, a global partnership of leading public health institutes in key endemic countries, to discover and develop new treatments for dengue.
What we’re doing for people with dengue
Together with our partners in the Dengue Alliance, we are actively searching for new treatments and have advanced two candidates to Phase II and III clinical trials. Our teams and partners are also carrying out much-needed research on the under-reported burden of dengue in Africa.
We are working with partners to repurpose existing direct-acting antivirals and host-directed therapies capable of inhibiting the inflammatory response characteristic of severe disease. DNDi teams are also working with partners to develop new antivirals effective against the dengue virus.
DNDi and partners are conducting retrospective dengue seroprevalence studies in Senegal, Ghana, and the Democratic Republic of the Congo (DRC) to better understand the burden of the disease in Africa and inform vaccine and vector-control strategies, as well as future treatments.
Scientists from DNDi and BenevolentAI use an artificial intelligence-driven approach to interrogate the underlying mechanisms involved in dengue and rapidly identify therapies that could be repurposed to prevent progression to severe dengue.
The Serum Institute of India and DNDi are working to advance a monoclonal antibody as a potential treatment that could help prevent progression to severe dengue and reduce dengue-related deaths.
Building capacity, uniting expertise
Research platforms and consortiums that bring together researchers and strengthen research capacities in low- and middle-income countries are central to our virtual R&D model.
Partnering for patients
Collaboration is an essential part of how we work. We have forged a diverse range of alliances and research collaborations with over 200 partners in nearly 50 countries.
Making medical history for neglected patients
We develop urgently needed treatments for neglected patients and ensure they’re affordable, available, and adapted to the communities who need them
Stay connected
Get our latest news, personal stories, research articles, and job opportunities.